Atherosclerotic renal artery stenosis: Association with emerging vascular risk factors

被引:26
|
作者
Paraskevas, Kosmas I. [3 ,4 ]
Hamilton, George [6 ]
Cross, Jenny M. [5 ]
Mikhailidis, Dimitri P. [1 ,2 ]
机构
[1] UCL Royal Free Hosp, Dept Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free Univ Coll, Sch Med, London NW3 2QG, England
[3] UCL Royal Free Hosp, Dept Clin Biochem, London, England
[4] UCL Royal Free Hosp, Acad Dept Surg, London, England
[5] UCL Royal Free Hosp, Renal Unit, London, England
[6] UCL Royal Free Hosp, Dept Surg, London NW3 2QG, England
来源
NEPHRON CLINICAL PRACTICE | 2008年 / 108卷 / 01期
关键词
atherosclerotic renal artery stenosis; renal function; homocysteine; fibrinogen; C-reactive protein; lipoprotein(a); creatinine;
D O I
10.1159/000112556
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The established risk factors for atherosclerotic renal artery stenosis (ARAS) include hypertension, diabetes mellitus, dyslipidemia, obesity, smoking, old age and family history. In the last few years, several emerging risk factors have been proposed as predictors of ARAS, namely homocysteine, fibrinogen, C-reactive protein, lipoprotein(a) and creatinine. Methods: We searched Pubmed/Medline for studies investigating the prognostic value of each of these emerging risk factors in ARAS. Results: Creatinine and C-reactive protein seem to be the most promising predictors of ARAS, whereas the prognostic value of homocysteine, lipoprotein(a) and fibrinogen is not yet fully determined. Conclusion: The establishment of a definite role for these emerging risk factors could result in earlier recognition and/or better management of ARAS with potential regression/slowing down of progression of stenosis. Modifying these markers may also improve the therapeutic approach of the associated systemic atherosclerosis in these high-risk patients. Future trials should focus on the effect of different classes of drugs (e. g. statins and fibrates) on the levels of the emerging risk factors and the association with ARAS progression. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:C56 / C66
页数:11
相关论文
共 50 条
  • [1] Emerging vascular risk factors in atherosclerotic renal artery stenosis
    Bessias, N.
    Georgakis, P.
    Tziviskou, E.
    Paraskevas, K. I.
    ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2009, 16 (01): : 41 - 49
  • [2] What is the role of emerging vascular risk factors in atherosclerotic renal artery stenosis?
    Paraskevas, Kosmas I.
    EUROPEAN JOURNAL OF RADIOLOGY, 2008, 68 (01) : 180 - 180
  • [3] Prevalence and risk factors of atherosclerotic renal artery stenosis
    严健华
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 89 - 90
  • [4] Association between Atherosclerotic Risk Factors and Distribution of Cerebral Artery Stenosis
    Liu, Z. Z.
    Si, L. P.
    Fang, F.
    Zhang, G.
    Wang, R. M.
    Kang, X. X.
    CARDIOLOGY, 2009, 114 : 140 - 141
  • [5] Hyperfibrinogenemia as a risk factor for atherosclerotic renal artery stenosis
    Kang, JY
    Yang, WS
    Kim, SB
    Park, SJ
    Park, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0665 - A0665
  • [6] Risk of atrophy in kidneys with atherosclerotic renal artery stenosis
    Caps, MT
    Zierler, RE
    Polissar, NL
    Bergelin, RO
    Beach, KW
    Cantwell-Gab, K
    Casadei, A
    Davidson, RC
    Strandness, ED
    KIDNEY INTERNATIONAL, 1998, 53 (03) : 735 - 742
  • [7] Prevalence and risk factors for atherosclerotic renal artery stenosis in elderly patients with refractory hypertension
    艾虎
    China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 85 - 85
  • [8] Atherosclerotic Renal Artery Stenosis
    Schoepe, Robert
    McQuillan, Stephen
    Valsan, Debbie
    Teehan, Geoffrey
    HYPERTENSION: FROM BASIC RESEARCH TO CLINICAL PRACTICE, VOL 2, 2017, 956 : 209 - 213
  • [9] Atherosclerotic renal artery stenosis
    Aronow, Wilbert S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (12)
  • [10] Atherosclerotic renal artery stenosis
    Robert D. Safian
    Current Treatment Options in Cardiovascular Medicine, 2003, 5 (2) : 91 - 101